Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by unNoteableon Oct 01, 2021 2:50pm
162 Views
Post# 33953469

RE:RE:RE:RE:Acceleron

RE:RE:RE:RE:Acceleron@ithno, it's the zealous self-righteous preaching, as though were all a done deal that annoys. Three years after they had a green light for the much vaunted phase III and what exactly has ONCY accomplished, in and of itself.

ONCY research is not even done in house. So just what have Matt and Co actually been doing for three effing years.

Why have none of the partners invested a dime to support this company? I'm at the point where I'd happily see this f'king thing burn to the ground, and have Kirk Look out on the streets of Calgary with his begging bowl and harmonica.

The product has potential, the management team are just a liability. Roll on success or failure.


<< Previous
Bullboard Posts
Next >>